. 2017 Apr-Jun;18(2):242–250.

Table 3.

Comparison of endocrinological characteristics among PCOS, PCOS-with- SCH patients and controls ^*

Variable ^**	PCOS TSH <4.2 μUI/ml		PCOS-with-SCH TSH ≥4.2 μUI/ml		Control TSH <4.2 μUI/ml

	n	Mean±SD	n	Mean±SD	n	Mean±SD
*TSH (mmol/l)*	417	1.99±0.86	30	7.83±7.48	195	1.96±0.81^a,b
*FT4 (pmol/l)*	402	14.31±2.39	27	12.68±2.91	191	13.93±2.08 ^a,c
*PRL (nmol/l)*	404	558.02±293.24	27	586.80±237.98	182	627.69±287.7^d
*E2 (pmol/l)*	301	185.57±66.67	18	173.08±58.46	157	163.93±63.48 ^e
*Tt (nmol/l)*	397	2.03±0.92	26	1.69±0.63	155	1.03±0.48 ^b,e
*FT (nmol/l)*	370	0.05±0.03	26	0.04±0.04	151	0.01±0.009 ^b,e
*SHBG (nmol/l)*	363	35.58±19.88	23	37.73±21.17	145	64.84±32.71^b,e
FAI (%)	352	7.46±5.37	21	5.97±3.70	139	2.05±1.85 ^b,e
*FSH (mUI/ml)*	397	5.77±1.77	25	6.43±1.61	178	7.18±2.14^e
*LH (mUI/ml)*	394	10.06±5.80	27	8.39±3.94	175	5.08±2.59 ^b,e
*17-OHP4 (nmol/l)*	390	0.038±0.021	27	0.033±0.014	145	0.028±0.030 ^e
*DHEAS (nmol/l)*	383	4.92±2.37	24	4.42±1.60	153	3.91±1.96 ^e
*Androstenedione (nmol/l)*	378	0.110±0.111	26	0.12±0.18	144	0.075±0.215^d

One way analysis of variance followed by post hoc Tukey test;

^**

PCOS=patients with PCOS and TSH<4.2 μUI/ml.

PCOS-with-SCH=patients with PCOS and TSH>4.2 μUI/ml. Control=normal women with TSH <4.2 μUI/ml

^a:

p<0.001 PCOS vs. PCOS-with-SCH;

^b:

p<0.001 PCOS-with-SCH vs. control;

^c:

p=0.041 PCOS-with-SCH vs. control;

^d:

p=0.007 PCOS vs. Control;

^e:

p<0.001 PCOS vs. control